Group items tagged

On June 15, 2011, the United States Food and Drug Administration informed the public that using the drug Actos, commonly prescribed in the treatment of Type 2 diabetes, has been positively associated with an increased risk of bladder cancer. Actos is manufactured by a Japanese pharmaceutical company, Takeda Pharmaceuticals, and is typically sold either as a single-ingredient product or in combination with the drug metformin. Actos is prescribed, along with diet and exercise, to help control blood sugar in adults. Initially the FDA's safety warnings were based on a five-year interim analysis of an ongoing ten year study regarding the risks for those taking Actos.

Topamax Warning? The Food and Drug Administration issued a "Drug Safety Communication" notifying the public of new evidence demonstrating increased risk for the development of oral birth defects in infants born to women who took Topamax (Topiramate) during pregnancy.